Repligen (RGEN) Cash from Investing Activities Growth (3y) (2013 - 2026)
Powered by 
Analysis
Repligen (RGEN) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -186.61% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -126.34% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -48.84% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 81.69% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -14.06% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -63.66% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -26.67% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -20.13% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 0.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.67% |
| Mar 31, 2026 | 24.95% |
| Dec 31, 2025 | -19.83% |
| Sep 30, 2025 | 48.65% |
| Jun 30, 2025 | 33.13% |
| Mar 31, 2025 | -37.97% |
| Dec 31, 2024 | -1.31% |
| Sep 30, 2024 | 64.66% |
| Jun 30, 2024 | 24.51% |
| Mar 31, 2024 | 2.41% |
| Dec 31, 2023 | -2.39% |
| Sep 30, 2023 | 36.08% |
| Jun 30, 2023 | 154.44% |
| Mar 31, 2023 | -23.26% |
| Dec 31, 2022 | -157.43% |
| Sep 30, 2022 | -102.81% |
| Jun 30, 2022 | 48.09% |
| Mar 31, 2022 | -94.61% |
| Dec 31, 2021 | -125.14% |
| Sep 30, 2021 | -216.94% |